Mustang inks a deal for in vivo CAR-T tech from the Mayo Clinic; How a spilled cup of tea landed one biotech $11.7 million
As part of its push to develop an off-the-shelf CAR-T therapy, Mustang Bio has inked a deal for new technology out …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
